The Drug Administration of Vietnam announces that it will give priority and shorten time of consideration for granting certificates of free sale to drugs which are being studied by countries for Covid-19 prevention and treatment (such as drugs containing Molnupiravir, Favipiravir, Remdesivir, etc.), thereby pharmaceutical companies should promptly submit the application for registration of marketing authorization.
In addition, if there are difficulties and problems relating the submission of application for registration of marketing authorization of drugs for Covid-19 prevention and treatment, units may propose solutions to remove difficulties to the Drug Administration of Vietnam.